title: [Wolff-Parkinson-White syndrome and verapamil: apropos of a case of ventricular fibrillation].
abstract: Numerous highly effective antiarrhythmic agents are now available which have a powerful anti-arrhythmia action but may cause severe side effects in the case of inappropriate use. We report the case of a patient with WPW syndrome in whom inappropriate administration of verapamil during an episode of atrial fibrillation and rapid ventricular response caused ventricular fibrillation.
authors.affiliation: Département de médecine, Centre hospitalier universitaire vaudois, Lausanne.
authors.forename: B
authors.initials: B
authors.lastname: Michel
authors.forename: J J
authors.initials: JJ
authors.lastname: Goy
authors.forename: L
authors.initials: L
authors.lastname: Kappenberger
mesh_terms: D000328:Adult; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D004562:Electrocardiography; D005260:Female; D006801:Humans; D014693:Ventricular Fibrillation / Q000139:chemically induced* / Q000175:diagnosis; D014700:Verapamil / Q000009:adverse effects* / Q000627:therapeutic use; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications* / Q000188:drug therapy
chemical_list: D014700:Verapamil
vernacular_title: Syndrome de Wolff-Parkinson-White et vérapamil: à propos d'un cas de fibrillation ventriculaire.